Stephen P. Mawer Sells 3,655 Shares of Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) Stock

Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) Director Stephen P. Mawer sold 3,655 shares of the company’s stock in a transaction dated Monday, March 24th. The stock was sold at an average price of $12.88, for a total transaction of $47,076.40. Following the completion of the transaction, the director now owns 287,307 shares of the company’s stock, valued at approximately $3,700,514.16. This trade represents a 1.26 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.

Calumet Specialty Products Partners Price Performance

Shares of NASDAQ CLMT remained flat at $12.23 during trading on Wednesday. The stock had a trading volume of 680,962 shares, compared to its average volume of 702,676. The company’s 50-day moving average is $15.05 and its two-hundred day moving average is $18.55. The stock has a market cap of $1.05 billion, a price-to-earnings ratio of -4.43 and a beta of 1.88. Calumet Specialty Products Partners, L.P. has a fifty-two week low of $9.97 and a fifty-two week high of $25.29.

Calumet Specialty Products Partners (NASDAQ:CLMT) last announced its quarterly earnings results on Friday, February 28th. The oil and gas company reported ($0.47) EPS for the quarter, beating the consensus estimate of ($1.06) by $0.59. The business had revenue of $949.50 million during the quarter, compared to analyst estimates of $921.76 million. The business’s revenue for the quarter was down 2.8% on a year-over-year basis. During the same period last year, the company earned ($0.59) EPS. On average, analysts anticipate that Calumet Specialty Products Partners, L.P. will post -3.02 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on the stock. HC Wainwright reaffirmed a “buy” rating and issued a $33.00 price target on shares of Calumet Specialty Products Partners in a research note on Monday, March 3rd. TD Cowen downgraded Calumet Specialty Products Partners from a “buy” rating to a “hold” rating and reduced their price objective for the company from $26.00 to $16.00 in a research note on Tuesday, March 4th. UBS Group raised shares of Calumet Specialty Products Partners from a “sell” rating to a “neutral” rating and lowered their target price for the stock from $15.00 to $12.00 in a research note on Monday, March 17th. Finally, Wells Fargo & Company reduced their target price on shares of Calumet Specialty Products Partners from $29.00 to $28.00 and set an “overweight” rating for the company in a research report on Wednesday, March 5th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $20.80.

About Calumet Specialty Products Partners

Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.